Table 1.
Baseline characteristics of the participants.
| N | 60% 1-RM | 70% 1-RM | 80% 1-RM | P value |
|---|---|---|---|---|
| 13 | 12 | 13 | — | |
| Age (years) | 20.7 ± 1.7 | 21.0 ± 0.9 | 20.9 ± 1.4 | 0.842 |
| Weight (kg) | 60.2 ± 5.0 | 58.2 ± 12.2 | 61.4 ± 8.1 | 0.666 |
| Height (m) | 1.64 ± 0.06 | 1.64 ± 0.08 | 1.65 ± 0.06 | 0.923 |
| BMI (kg/m2) | 22.4 ± 2.4 | 21.4 ± 2.5 | 22.6 ± 3.5 | 0.536 |
| EPCs (%) | 8.69E−03 ± 0.97E−03 | 7.65E−03 ± 0.42E−03 | 7.87E−03 ± 0.37E−03 | 0.505 |
| EPO (mU/mL) | 10.1 ± 3.7 | 12.4 ± 7.6 | 11.7 ± 4.9 | 0.588 |
| HIF-1α (pg/mL) | 322.9 ± 203.7 | 320.4 ± 240.9 | 321.6 ± 179.3 | 1.000 |
| SDF-1 (pg/mL) | 1312.6 ± 486.5 | 1377.2 ± 343.1 | 1327.3 ± 471.4 | 0.930 |
| VEGF (pg/mL) | 52.0 ± 6.5 | 51.7 ± 6.3 | 52.4 ± 8.9 | 0.971 |
BMI, body mass index; EPCs, endothelial progenitor cells; EPO, erythropoietin; SDF-1α, stromal cell-derived factor 1; VEGF, vascular endothelial growth factor; HIF-1α, hypoxia-inducible factor 1-alpha and EPO, erythropoietin; P values are for between group comparisons with one-way ANOVA.